Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The development of Nanosota-1 as anti-SARS-CoV-2 nanobody drug candidates
Gang Ye, Joseph P. Gallant, Jian Zheng, et al.
eLife (2021) Vol. 10
Open Access | Times Cited: 55

Showing 1-25 of 55 citing articles:

Nanobody cocktails potently neutralize SARS-CoV-2 D614G N501Y variant and protect mice
Phillip Pymm, Amy Adair, Li‐Jin Chan, et al.
Proceedings of the National Academy of Sciences (2021) Vol. 118, Iss. 19
Open Access | Times Cited: 143
Nanobodies: Robust miniprotein binders in biomedicine
Jeffrey Yong Joon Kim, Zhe Sang, Yufei Xiang, et al.
Advanced Drug Delivery Reviews (2023) Vol. 195, pp. 114726-114726
Open Access | Times Cited: 44
Highly synergistic combinations of nanobodies that target SARS-CoV-2 and are resistant to escape
Fred D. Mast, Peter C. Fridy, Natalia E. Ketaren, et al.
eLife (2021) Vol. 10
Open Access | Times Cited: 58
Therapeutic nanobodies against SARS-CoV-2 and other pathogenic human coronaviruses
Yang Yang, Fang Li, Lanying Du
Journal of Nanobiotechnology (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 9
Novel Nanobody Drug Conjugate as a Prophylactic or Therapeutic against SARS-CoV-2 infection in mice
Brian Imbiakha, Shahrzad Ezzatpour, David W. Buchholz, et al.
Biochemical and Biophysical Research Communications (2025) Vol. 753, pp. 151480-151480
Closed Access | Times Cited: 1
Recent advances in nanotechnology-based COVID-19 vaccines and therapeutic antibodies
Lanying Du, Yang Yang, Xiujuan Zhang, et al.
Nanoscale (2022) Vol. 14, Iss. 4, pp. 1054-1074
Open Access | Times Cited: 31
The Potential of Nanobodies for COVID-19 Diagnostics and Therapeutics
Dhaneshree Bestinee Naidoo, Anil A. Chuturgoon
Molecular Diagnosis & Therapy (2023) Vol. 27, Iss. 2, pp. 193-226
Open Access | Times Cited: 20
Superimmunity by pan-sarbecovirus nanobodies
Yufei Xiang, Wei Huang, Hejun Liu, et al.
Cell Reports (2022) Vol. 39, Iss. 13, pp. 111004-111004
Open Access | Times Cited: 28
Arsenal of nanobodies shows broad-spectrum neutralization against SARS-CoV-2 variants of concern in vitro and in vivo in hamster models
Martín A. Rossotti, Henk van Faassen, Anh Tran, et al.
Communications Biology (2022) Vol. 5, Iss. 1
Open Access | Times Cited: 27
Correlation between the binding affinity and the conformational entropy of nanobody SARS-CoV-2 spike protein complexes
Halina Mikolajek, Miriam Weckener, Z. Faidon Brotzakis, et al.
Proceedings of the National Academy of Sciences (2022) Vol. 119, Iss. 31
Open Access | Times Cited: 26
Outlook of therapeutic and diagnostic competency of nanobodies against SARS-CoV-2: A systematic review
Hamid Aria, Fatemeh Mahmoodi, Hooria Seyedhosseini Ghaheh, et al.
Analytical Biochemistry (2022) Vol. 640, pp. 114546-114546
Open Access | Times Cited: 25
A Glycosylated RBD Protein Induces Enhanced Neutralizing Antibodies against Omicron and Other Variants with Improved Protection against SARS-CoV-2 Infection
Juan Shi, Jian Zheng, Wanbo Tai, et al.
Journal of Virology (2022) Vol. 96, Iss. 17
Open Access | Times Cited: 24
Discovery of Nanosota-2, -3, and -4 as super potent and broad-spectrum therapeutic nanobody candidates against COVID-19
Gang Ye, Ruangang Pan, Fan Bu, et al.
Journal of Virology (2023) Vol. 97, Iss. 11
Open Access | Times Cited: 15
Aptamers and Nanobodies as New Bioprobes for SARS-CoV-2 Diagnostic and Therapeutic System Applications
Ki Sung Park, Tae-In Park, Jae Eon Lee, et al.
Biosensors (2024) Vol. 14, Iss. 3, pp. 146-146
Open Access | Times Cited: 6
SARS-CoV-2 Specific Nanobodies Neutralize Different Variants of Concern and Reduce Virus Load in the Brain of h-ACE2 Transgenic Mice
María F. Pavan, Marina Bok, Rafael Betanzos San Juan, et al.
Viruses (2024) Vol. 16, Iss. 2, pp. 185-185
Open Access | Times Cited: 5
Nanobody in a Double “Y”-Shaped Assembly: A Promising Candidate for Lateral Flow Immunoassays
Yumeng Xiao, Hongjie Dong, Cancan Wu, et al.
Analytical Chemistry (2024) Vol. 96, Iss. 18, pp. 7130-7137
Closed Access | Times Cited: 5
Mechanisms of SARS-CoV-2 neutralization by shark variable new antigen receptors elucidated through X-ray crystallography
Obinna C. Ubah, Eric W. Lake, Gihan S. Gunaratne, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 28
Nanobodies to multiple spike variants and inhalation of nanobody-containing aerosols neutralize SARS-CoV-2 in cell culture and hamsters
Metin Aksu, Priya Kumar, Thomas Güttler, et al.
Antiviral Research (2023) Vol. 221, pp. 105778-105778
Open Access | Times Cited: 13
Structure-guided in vitro evolution of nanobodies targeting new viral variants
Gang Ye, Fan Bu, Ruangang Pan, et al.
PLoS Pathogens (2024) Vol. 20, Iss. 9, pp. e1012600-e1012600
Open Access | Times Cited: 4
Structural Biology of Nanobodies against the Spike Protein of SARS-CoV-2
Qilong Tang, Raymond J. Owens, James H. Naismith
Viruses (2021) Vol. 13, Iss. 11, pp. 2214-2214
Open Access | Times Cited: 24
Preparation of a Nanobody Specific to Dectin 1 and Its Anti-inflammatory Effects on Fungal Keratitis
Xing Liu, Jianxin Sui, Cui Li, et al.
International Journal of Nanomedicine (2022) Vol. Volume 17, pp. 537-551
Open Access | Times Cited: 18
Nebulized delivery of a broadly neutralizing SARS-CoV-2 RBD-specific nanobody prevents clinical, virological, and pathological disease in a Syrian hamster model of COVID-19
Thomas J. Esparza, Yaozong Chen, Negin P. Martin, et al.
mAbs (2022) Vol. 14, Iss. 1
Open Access | Times Cited: 17
RBD-mRNA vaccine induces broadly neutralizing antibodies against Omicron and multiple other variants and protects mice from SARS-CoV-2 challenge
Juan Shi, Jian Zheng, Xiujuan Zhang, et al.
Translational research (2022) Vol. 248, pp. 11-21
Open Access | Times Cited: 17
Identification of a Linear B Cell Epitope on p54 of African Swine Fever Virus Using Nanobodies as a Novel Tool
Huijun Zhao, Gaijie Wang, Haoxin Dong, et al.
Microbiology Spectrum (2023) Vol. 11, Iss. 3
Open Access | Times Cited: 10
Structural and Computational Studies of the SARS-CoV-2 Spike Protein Binding Mechanisms with Nanobodies: From Structure and Dynamics to Avidity-Driven Nanobody Engineering
Gennady M. Verkhivker
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 6, pp. 2928-2928
Open Access | Times Cited: 16
Page 1 - Next Page

Scroll to top